Emergency Preparedness and Response
Resources for You
Animation of Antimicrobial Resistance
- Antimicrobial Resistance information from FDA Center for Veterinary Medicine
- FDA's Animal and Veterinary Strategy on Antimicrobial Resistance - Questions and Answers
NIH Fact Sheet on Antimicrobial Resistance Interagency Task Force on Antimicrobial Resistance
- List of Qualifying Pathogens under the Generating Antibiotic Incentives Now (GAIN) title of FDASIA
- HHS ASPR Blog Series: Combatting Antibiotic Resistance
The Development of New Antibacterial Products: Charting a Course for the Future
July 30-31, 2014
Bethesda North Marriott Hotel & Conference Center
5701 Marinelli Road
North Bethesda, MD 20852
The National Institutes of Health (NIH) and FDA will host a two-day workshop to explore key issues and challenges related to antibacterial product development and discuss the development of streamlined regulatory pathways for bringing new antibacterial drugs to market.
The workshop aims to identify strategies for promoting clinical trials for antibacterial drugs and encouraging partnerships to accelerate the development of new antibacterial drugs.
Specific issues to be discussed include:
- Priorities and strategic approaches to conducting clinical trials for antibacterial drugs
- Regulatory pathways—including streamlined development programs for the development of antibacterial drugs for patients with limited or no treatment options
- Clinical trial design issues including: the development of a common clinical protocol; using common control groups; statistical design issues; data sharing across trials (and data standards); appropriate clinical trial endpoints; and lessons learned from other therapeutic areas
- The role of public private partnerships in advancing the scientific and clinical trials enterprises
This workshop is open to the public. Due to space limitations, pre-registration is encouraged; registration deadline is Monday, July 14, 2014.
If you require assistance registering, please contact Monica Barnette at (301) 650-8660 or email@example.com.
Federal Register notice about this event (July 1, 2014)